New H_1/H₃ antagonists for treating allergic rhinitis: WO2010094643

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.21, Iss.3, 2011-03, pp. : 425-429

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A H₃ antagonist for treating allergic rhinitis: a development candidate?

By Norman Dr Peter

Expert Opinion on Therapeutic Patents, Vol. 17, Iss. 4, 2007-04 ,pp. : 449-452

Informa Healthcare

Access to resources Recommend Favorite

3-Hydroxy-6,7-dihydropyrimido[2,1-c][1,4]oxazin-4(9H)-ones as new HIV-1 integrase inhibitors WO2011046873 A1

By Cotelle Philippe

Expert Opinion on Therapeutic Patents, Vol. 21, Iss. 11, 2011-11 ,pp. : 1799-1804

Informa Healthcare

Access to resources Recommend Favorite

New potent histamine H 3 -receptor antagonists of the amide type

By Stark H. Lipp R. Arrang J.-M. Garbarg M. Ligneau X. Schwartz J.-C. Schunack W.

European Journal of Pharmaceutical Sciences, Vol. 3, Iss. 2, 1995-04 ,pp. : 95-104

Elsevier

Access to resources Recommend Favorite

Histamine H₃ receptor antagonists

By Tozer M.J. Kalindjian S.B.

Expert Opinion on Therapeutic Patents, Vol. 10, Iss. 7, 2000-07 ,pp. : 1045-1055

Informa Healthcare

Access to resources Recommend Favorite

Stimulating Effects of H1-Antagonists

Current Pharmaceutical Design, Vol. 12, Iss. 20, 2006-07 ,pp. : 2501-2509

Bentham Science Publishers

Access to resources Recommend Favorite